LONDON: British Prime Minister Boris Johnson will set the government winter plan to manage Covid-19 this week, said Downing Street, Monday.
The vaccine will continue to be a “first defense line” during the upcoming autumn and winter months, supported by new care, testing, and the “world-leading” English variant supervision system, with further locking is expected to be ruled out.
Under the autumn-winter proposal, the government will revoke several strengths of his emergency Coronavirus law, which was brought to overcome last year’s pandemic.
“Thanks to the public efforts, the NHS and our phenomenal vaccination program, we reached step 4 in our roadmap and our lives (Kuncian) we have returned to the sense of normality,” Johnson said, ahead of the press conference planned on Tuesday.
“Sometimes this extraordinary time is needed but intrusion steps.
But I am determined to get rid of all the forces we no longer need because of our vaccine defense.
I will set the next phase in our Covid response immediately,” he said.
Downing Street said that while certain strengths, such as closing economic sectors, schools and detention of contagious people will leave, some vital powers of the Coronavirus law will be maintained to protect and support the community.
This includes paying sickness to those isolated from the first day of the day seven, directing the school to remain open if they close against government guidance, and assist the National Health Office (NHS) to obtain emergency resources needed.
Legal requirements will remain someone to isolate if they test positively, to protect the most vulnerable from infection and to control the spread of variants.
Downing Street said that on September 9, almost 90 percent of the British population over the age of 16 had received the first dose of Covid vaccine, and more than 80 percent had received both doses.
The latest data from Health Public England (PHE) shows the Covid vaccine is very effective against the inpatient variant of Delta (B.1.617.2), first detected in India and currently dominant tensions in the UK.
The analysis shows the Pfizer / Biontech vaccine is 96 percent effective and Oxford / Astrazeneca vaccine – given in India as a covishield – is 92 percent effective against hospitalization after two doses.
“The winter months will bring new challenges.
Covid will circulate with flu and other respiratory viruses and the threat of new variants still exists.
It is difficult to predict for sure how this will interact and pressure what they place on the NHS,” Downing.
Word.
“Independent Expert Committee – Combined Committee on Vaccination and Immunization (JCVI) – Requested to consider the Covid vaccine amplifier program.
Temporary advice suggests planning a booster vaccine to be launched to the most vulnerable from September 2021, to offer an increase in the level of protection during the winter,” he said.
The British government said it expects to accept confirmation this week from JCVI in the details of vaccination amplifier programs, with plans to start this month.
It is intended to increase immunity to Covid-19 during the winter months, protect against serious diseases and unsustainable deaths and NHS.
The government confirmed last week that they were specifically vulnerable and immunocompromised will be offered a third primary dose.
It is separate from the Booster program, because this category requires a third primary dose due to inadequate protection of two doses.